Neuroone Medical Technologies is trading at $1.68, down 5.07% in pre-market on August 31, 2026, with no clearly identified company-specific catalyst.
- The latest reported event, August 27’s successful completion of three large-animal StereoCED procedures, was positive and does not directly explain the decline.
- Broader U.S. futures were only modestly lower; the move may reflect low-liquidity trading or a delayed reaction to prior selling.